Insilicare
Insilicare provides AI-powered digital twins for ICU patients to predict and prevent life-threatening complications, particularly hypoglycemia.
Insilicare creates digital twins for ICU patients using AI to predict life-threatening complications hours before they occur. The platform focuses on insulin therapy optimization, claiming 98.6% hypoglycemia reduction, 35% clinical burden reduction, and 80% glycemia in target.
Key People
Vincent Uyttendaele - Founder - CEO